Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-25-107829
Filing Date
2025-11-06
Accepted
2025-11-06 16:59:01
Documents
60
Period of Report
2025-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q gpcr-20250930x10q.htm   iXBRL 10-Q 2254147
2 EX-10.1 gpcr-20250930xex10d1.htm EX-10.1 321937
3 EX-10.2 gpcr-20250930xex10d2.htm EX-10.2 41417
4 EX-31.1 gpcr-20250930xex31d1.htm EX-31.1 16146
5 EX-31.2 gpcr-20250930xex31d2.htm EX-31.2 16243
6 EX-32.1 gpcr-20250930xex32d1.htm EX-32.1 9850
7 EX-32.2 gpcr-20250930xex32d2.htm EX-32.2 10137
8 GRAPHIC gpcr-20250930x10q001.jpg GRAPHIC 99035
  Complete submission text file 0001104659-25-107829.txt   8015408

Data Files

Seq Description Document Type Size
9 EX-101.SCH gpcr-20250930.xsd EX-101.SCH 41172
10 EX-101.CAL gpcr-20250930_cal.xml EX-101.CAL 46096
11 EX-101.DEF gpcr-20250930_def.xml EX-101.DEF 179137
12 EX-101.LAB gpcr-20250930_lab.xml EX-101.LAB 363572
13 EX-101.PRE gpcr-20250930_pre.xml EX-101.PRE 260851
63 EXTRACTED XBRL INSTANCE DOCUMENT gpcr-20250930x10q_htm.xml XML 1137577
Mailing Address 601 GATEWAY BLVD SUITE 900 SOUTH SAN FRANCISCO CA 94080
Business Address 601 GATEWAY BLVD SUITE 900 SOUTH SAN FRANCISCO CA 94080 (650) 457-1978
Structure Therapeutics Inc. (Filer) CIK: 0001888886 (see all company filings)

EIN.: 981480821 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41608 | Film No.: 251459361
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)